Ben Tre Pharmaceutical announced that it had appointed Tran Ngo Minh Anh (トラン・ゴ・ミン・アイン), born in 2002, as general director effective 1 November 2026. The appointment was subject to her consent, and the formal transition was completed on the same date.
The board of directors of Ben Tre Pharmaceutical JSC approved the appointment of Tran Ngo Minh Anh (トラン・ゴ・ミン・アイン), born in 2002, as general director effective 1 November 2026. Anh will take office as the company's new general director. The appointment followed the resignation of Nguyen Khac Hanh (グエン・カック・ハイン).
Anh was born in Lam Dong Province and is said to be the daughter of the chairman of the board of Nam A Commercial Bank. She earned a bachelor's degree in finance from the University of Central Florida and worked at New Omni Bank from 2024 to 2026, before returning to Vietnam in August 2026 and joining Befarco. She was elected as a director at an extraordinary general meeting and served as deputy general director before becoming general director.
Ben Tre Pharmaceutical was founded in 1976, and its privatization was completed in 2004. Its initial capital was VND 20 billion, with the government holding 51% and controlling the company, a structure that later changed. The company was listed on the Hanoi Stock Exchange in 2009 under the ticker DBT, and its major shareholders were reorganized from 2013 to 2014. The government's sale was completed at the end of 2014, making the company fully private. The company completed its transfer of listing to HOSE in 2020 and is seeking to expand its fundraising capacity and business scale.
For additional background, the company reached its current position after transferring its listing to the Ho Chi Minh Stock Exchange. The latest management change is viewed as an effort to strengthen the company's organizational structure.